nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Agmatine (decarboxylated l-arginine): Physiological role and therapeutic potential
|
Molderings, Gerhard J. |
|
2012 |
133 |
3 |
p. 351-365 15 p. |
artikel |
2 |
Cardiovascular pharmacogenetics
|
Myburgh, Renier |
|
2012 |
133 |
3 |
p. 280-290 11 p. |
artikel |
3 |
Formation of P450·P450 complexes and their effect on P450 function
|
Reed, James R. |
|
2012 |
133 |
3 |
p. 299-310 12 p. |
artikel |
4 |
Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections
|
Geurts, Nathalie |
|
2012 |
133 |
3 |
p. 257-279 23 p. |
artikel |
5 |
Myeloid differentiation 2 as a therapeutic target of inflammatory disorders
|
Park, Sun Hong |
|
2012 |
133 |
3 |
p. 291-298 8 p. |
artikel |
6 |
Role of ranolazine in angina, heart failure, arrhythmias, and diabetes
|
Sossalla, Samuel |
|
2012 |
133 |
3 |
p. 311-323 13 p. |
artikel |
7 |
Stable isotope-resolved metabolomics and applications for drug development
|
Fan, Teresa W.-M. |
|
2012 |
133 |
3 |
p. 366-391 26 p. |
artikel |
8 |
Targeting DNA damage and repair: Embracing the pharmacological era for successful cancer therapy
|
Aziz, K. |
|
2012 |
133 |
3 |
p. 334-350 17 p. |
artikel |
9 |
Transglutaminase 2: Biology, Relevance to Neurodegenerative Diseases and Therapeutic Implications
|
Grosso, Hilary |
|
2012 |
133 |
3 |
p. 392-410 19 p. |
artikel |
10 |
Voltage-gated calcium channels and Parkinson's disease
|
Hurley, Michael J. |
|
2012 |
133 |
3 |
p. 324-333 10 p. |
artikel |